The purpose of this funding opportunity announcement (FOA) is to solicit applications for the Sexually Transmitted Infections Cooperative Research Centers (STI CRC) program.
This STI CRC program will facilitate multidisciplinary, synergistic collaborations to support the development of vaccines
to control and prevent sexually transmitted infections (STIs) caused by the following pathogens, which have limited candidates in the product development pipeline:
Neisseria gonorrhoeae, Chlamydia trachomatis, and Treponema pallidum.
In addition, the FOA will support the development of prophylactic vaccines for herpes simplex virus (HSV).